Gut bacteria in alcoholic hepatitis
Treatments studied
Part of Digestive system clinical trials.
This trial is looking at bacteria inside the liver of people with alcoholic hepatitis. It may help understand how these bacteria affect the disease and lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have alcoholic liver disease with a sudden yellowing of the skin or eyes (jaundice) and heavy alcohol use, either still drinking or stopped for 3 months or less.
- Your doctor must decide you need a special type of liver biopsy done through a vein in the neck (transjugular).
- You must be 18 years old or older.
- You should not have taken antibiotics or probiotics for at least 15 days before the procedure, except for certain infection-prevention antibiotics.
- You cannot have liver cancer at the planned biopsy spot, be pregnant or breastfeeding, or be under legal guardianship or in prison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
This study looks at how immune cells in the blood respond in people with alcoholic hepatitis and in people who drink heavily (with no known liver disease). It may help researchers understand why liver inflammation happens after heavy alcohol use.
This study looks at how alcoholic liver disease may change a natural body clean-up process in muscle. It compares people with alcoholic liver disease to people without it to better understand the biology and identify possible targets for treatment.
This study follows adults with alcohol-related liver disease to better understand and manage alcohol addiction and related health problems. You may be able to help researchers by sharing health information and consented care experiences.
This study looks at genetic differences in people with alcohol-related liver illness, including a recent jaundice episode (alcoholic hepatitis). By following people over time, it may help doctors better predict illness and understand why some people develop worse liver problems.
This trial tests a new medicine called MRG-001 for people with severe alcoholic hepatitis, a liver condition caused by heavy drinking. The study aims to see if the drug can help improve liver function and reduce symptoms.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.